- Home
- CTOS vs CLDX Comparison
CTOS vs CLDX Comparison
Compare CTOS & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOS
- CLDX
- Stock Information
- Founded
- CTOS 1988
- CLDX N/A
- Country
- CTOS United States
- CLDX United States
- Employees
- CTOS N/A
- CLDX N/A
- Industry
- CTOS Diversified Commercial Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CTOS Consumer Discretionary
- CLDX Health Care
- Exchange
- CTOS Nasdaq
- CLDX Nasdaq
- Market Cap
- CTOS 1.4B
- CLDX 1.6B
- IPO Year
- CTOS N/A
- CLDX 2008
- Fundamental
- Price
- CTOS $6.21
- CLDX $26.22
- Analyst Decision
- CTOS Buy
- CLDX Strong Buy
- Analyst Count
- CTOS 3
- CLDX 8
- Target Price
- CTOS $6.83
- CLDX $46.13
- AVG Volume (30 Days)
- CTOS 809.8K
- CLDX 1.1M
- Earning Date
- CTOS 10-29-2025
- CLDX 11-05-2025
- Dividend Yield
- CTOS N/A
- CLDX N/A
- EPS Growth
- CTOS N/A
- CLDX N/A
- EPS
- CTOS N/A
- CLDX N/A
- Revenue
- CTOS $1,901,675,000.00
- CLDX $5,790,000.00
- Revenue This Year
- CTOS $13.58
- CLDX N/A
- Revenue Next Year
- CTOS $5.18
- CLDX N/A
- P/E Ratio
- CTOS N/A
- CLDX N/A
- Revenue Growth
- CTOS 6.21
- CLDX N/A
- 52 Week Low
- CTOS $3.03
- CLDX $14.40
- 52 Week High
- CTOS $6.64
- CLDX $31.66
- Technical
- Relative Strength Index (RSI)
- CTOS 53.56
- CLDX 60.30
- Support Level
- CTOS $6.28
- CLDX $24.49
- Resistance Level
- CTOS $6.59
- CLDX $26.90
- Average True Range (ATR)
- CTOS 0.24
- CLDX 1.00
- MACD
- CTOS 0.03
- CLDX 0.07
- Stochastic Oscillator
- CTOS 61.98
- CLDX 79.27
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.